5. Conclusions
cardiometabolic disorders, inflammation, RET, sarcopenia
INFLAMMATION, OXIDATIVE STRESS, SYNDROMES, SARCOPENIA
The present study illustrates that FO administration over an 8 wk period of programmed RET amplifies the beneficial effects of RET on muscle strength. Simultaneously, it helps mitigate risk factors linked to cardiometabolic disorders in older females. Particularly, the combination of FO administration with RET exhibits potent anti-inflammatory and antioxidant properties, providing potential protection against the onset of various geriatric syndromes linked to chronic low-grade inflammation and/or aberrant oxidative stress in older women. The pivotal findings of the present study carry meaningful implications, serving as a foundation for forthcoming clinical investigations. Further studies are warranted to ascertain the clinical efficacy of FO treatment in counteracting the risk factors associated with sarcopenia and cardiometabolic disorders in postmenopausal women.